Scinai Immunotherapeutics Ltd.SCNIEarnings & Financial Report
Nasdaq
SCNI Q2 2025 Key Financial Metrics
Revenue
$773.0K
Gross Profit
$-1.3M
Operating Profit
N/A
Net Profit
N/A
Gross Margin
-164.3%
Operating Margin
N/A
Net Margin
N/A
YoY Growth
172.2%
Financial Flow
Scinai Immunotherapeutics Ltd. Q2 2025 Financial Summary
Scinai Immunotherapeutics Ltd. reported revenue of $773.0K (up 172.2% YoY) for Q2 2025, with a net profit of N/A (N/A margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $773.0K |
|---|---|
| Net Profit | N/A |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q2 2025 |
Scinai Immunotherapeutics Ltd. Quarterly Revenue & Net Profit History
Scinai Immunotherapeutics Ltd. quarterly results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 2025 | $773.0K | +172.2% | N/A | N/A |
| Q2 2024 | $284.0K | — | N/A | N/A |
Income Statement
| Q2 2024 | Q2 2025 | |
|---|---|---|
| Revenue | $284000 | $773000 |
| YoY Growth | N/A | 172.2% |
Balance Sheet
| Q2 2024 | Q2 2025 | |
|---|---|---|
| Assets | $14.9M | $11.8M |
| Liabilities | $22.1M | $4.0M |
| Equity | $-7.3M | $7.9M |
Cash Flow
No data available for this period